Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEXECUTIVESQuantum Health Names Drew Domecq Chief Technology Officer + Peter McClennen Added to BOD

Quantum Health Names Drew Domecq Chief Technology Officer + Peter McClennen Added to BOD

Quantum Health, the industry-leading healthcare navigation and care coordination company, announced today that Drew Domecq has joined the company as its chief technology officer.

The addition of Domecq to the company’s already deep technical bench underscores Quantum Health’s continued commitment to raising the bar on human-centered innovation and outcomes through its proprietary integration of technology, data analytics, and personalized care coordination.

“Technology and data analytics are powerful unlockers to more personalized, responsive, and higher-quality consumer healthcare journeys,” said Shannon Skaggs, president of Quantum Health. “We are excited to have Drew join our leadership team. His experience leading technology innovation driven by creating world-class consumer experiences aligns perfectly with our mission.”

Prior to joining Quantum Health, Domecq was executive vice president and chief information officer at Designer Brands (formerly DSW Inc.), where he was responsible for applying technology enablement to their growth strategy. Before Designer Brands, Domecq was chief information officer at Bob Evans and held technology leadership positions at The Wendy’s Company; Vox Mobile, Inc.; Safelite Group, Inc.; and Qwest Communications International, Inc.

Domecq earned bachelor’s degrees in politics and economics from Princeton University and a master’s in business administration from the Kellogg School of Management at Northwestern University.

“Healthcare is one of the most important and personal interactions we experience as humans, yet the consumer perspective is often completely lost within an overly complicated system,” said Domecq. “Quantum Health realized long ago that technology and data play a crucial role in understanding what consumers want and need as they progress along their healthcare journeys. I am inspired by Quantum Health’s culture and mission and am thrilled to join the Quantum Health team as it continues to lead the consumer navigation industry; especially now, when consumers need expert support and guidance more than ever.”

Quantum Health also announced that Peter McClennen has joined its board of directors. McClennen, who was most recently president at Teladoc Health, adds to Quantum Health’s deep expertise in clinical care, healthcare provider relationships, technology, and harnessing healthcare data analytics. Prior to his position at Teladoc, McClennen held executive leadership positions at Best Doctors, Allscripts, and dbMotion, Inc.

Quantum Health adds Peter McClennen to board of directors.

“Peter has amassed valuable experience in areas that are critically important to transforming the consumer healthcare experience today,” said Kara Trott, founder and CEO of Quantum Health. “His understanding of technology-based care delivery, along with his expertise in healthcare innovation, analytics and informatics are a perfect complement to our esteemed board of directors already in place.”

McClennen shares Quantum Health’s mission to keep the consumer at the center of the healthcare experience. “Understanding healthcare consumers’ challenges is essential to reshaping their experiences and improving outcomes. Quantum Health does this like no other company. Using data to understand and transform the consumer healthcare journey is the very foundation upon which the company is built,” said McClennen. “In an extremely noisy marketplace, I share their deep commitment to delivering measurable results — for both the consumer and the self-insured employers that provide their benefits. I am very pleased to be part of this organization as it continues to lead the healthcare navigation space.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy